Cover Image
市場調查報告書

微量蛋白尿:全球臨床實驗趨勢

Microalbuminuria Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 325942
出版日期 內容資訊 英文 87 Pages
訂單完成後即時交付
價格
Back to Top
微量蛋白尿:全球臨床實驗趨勢 Microalbuminuria Global Clinical Trials Review, H2, 2015
出版日期: 2015年09月10日 內容資訊: 英文 87 Pages
簡介

本報告提供微量蛋白尿相關之臨床研究最新趨勢調查,提供您地區·進展·PHASE·募集情況別的實驗量,代表性贊助商,開發中的治療藥資訊,並彙整全球各國的主要企業·機關的進展,有潛力的藥劑比較等資訊。

簡介

  • 微量蛋白尿
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:泌尿系統生殖器系·性荷爾蒙治療藥臨床實驗上微量蛋白尿的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:泌尿系統生殖器系·性荷爾蒙治療藥臨床實驗上微量蛋白尿的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

微量蛋白尿治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Steno Diabetes Center A/S
    • Novartis AG
    • 武田藥品工業
    • Sanofi
    • Bristol-Myers Squibb Company
    • Pfizer Inc.
    • Keryx Biopharmaceuticals, Inc.
    • GlaxoSmithKline plc
    • AstraZeneca PLC
  • 有代表性的研究機關·醫院臨床實驗概要
    • Hospital de Clinicas de Porto Alegre
    • University Medical Center Groningen
    • 滋賀醫科大學
    • 順天堂大學 School of Medicine
    • University Medical Centre Ljubljana
    • University of Pavia
    • Postgraduate Institute of Medical Education and Research
    • University of Campinas, Brazil
    • Seoul National University Hospital
    • Akershus University Hospital

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2851CTIDB

GlobalData's clinical trial report, "Microalbuminuria Global Clinical Trials Review, H2, 2015" provides an overview of Microalbuminuria clinical trials scenario. This report provides top line data relating to the clinical trials on Microalbuminuria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Microalbuminuria
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Microalbuminuria
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Microalbuminuria Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Steno Diabetes Center A/S
      • Clinical Trial Overview of Steno Diabetes Center A/S
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Alfa Wassermann S.p.A
      • Clinical Trial Overview of Alfa Wassermann S.p.A
      • Fondazione Mario Negri Sud
      • Clinical Trial Overview of Fondazione Mario Negri Sud
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • AstraZeneca Plc
      • Clinical Trial Overview of AstraZeneca Plc
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Hospital de Clinicas de Porto Alegre
      • Clinical Trial Overview of Hospital de Clinicas de Porto Alegre
      • Akershus University Hospital
      • Clinical Trial Overview of Akershus University Hospital
      • Asahikawa Medical College
      • Clinical Trial Overview of Asahikawa Medical College
      • Charles Drew University of Medicine and Science
      • Clinical Trial Overview of Charles Drew University of Medicine and Science
      • Chengdu University of Traditional Chinese Medicine
      • Clinical Trial Overview of Chengdu University of Traditional Chinese Medicine
      • Chiba University Hospital
      • Clinical Trial Overview of Chiba University Hospital
      • Chongqing Medical University (Inactive)
      • Clinical Trial Overview of Chongqing Medical University (Inactive)
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
      • Gujarat Ayurved University
      • Clinical Trial Overview of Gujarat Ayurved University
      • Hospital Universitari Vall d'Hebron
      • Clinical Trial Overview of Hospital Universitari Vall d'Hebron
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Microalbuminuria Therapeutics, Global, Clinical Trials by Region, 2015*
  • Microalbuminuria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Microalbuminuria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Microalbuminuria Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Microalbuminuria Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Microalbuminuria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Microalbuminuria Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Microalbuminuria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Microalbuminuria Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Microalbuminuria Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Microalbuminuria Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Microalbuminuria Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Microalbuminuria Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Microalbuminuria Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Steno Diabetes Center A/S, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfa Wassermann S.p.A, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Fondazione Mario Negri Sud, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital de Clinicas de Porto Alegre, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Akershus University Hospital, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Asahikawa Medical College, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Charles Drew University of Medicine and Science, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Chengdu University of Traditional Chinese Medicine, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University Hospital, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Chongqing Medical University (Inactive), 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Gujarat Ayurved University, 2015*
  • Microalbuminuria Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitari Vall d'Hebron, 2015*

List of Figures

  • Microalbuminuria Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Microalbuminuria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Microalbuminuria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Microalbuminuria Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Microalbuminuria Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Microalbuminuria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Microalbuminuria to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Microalbuminuria Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Microalbuminuria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Microalbuminuria Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Microalbuminuria Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Microalbuminuria Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Microalbuminuria Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Microalbuminuria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top